PLoS Biology (Nov 2011)

Copy number variation of KIR genes influences HIV-1 control.

  • Kimberly Pelak,
  • Anna C Need,
  • Jacques Fellay,
  • Kevin V Shianna,
  • Sheng Feng,
  • Thomas J Urban,
  • Dongliang Ge,
  • Andrea De Luca,
  • Javier Martinez-Picado,
  • Steven M Wolinsky,
  • Jeremy J Martinson,
  • Beth D Jamieson,
  • Jay H Bream,
  • Maureen P Martin,
  • Persephone Borrow,
  • Norman L Letvin,
  • Andrew J McMichael,
  • Barton F Haynes,
  • Amalio Telenti,
  • Mary Carrington,
  • David B Goldstein,
  • Galit Alter,
  • NIAID Center for HIV/AIDS Vaccine Immunology

DOI
https://doi.org/10.1371/journal.pbio.1001208
Journal volume & issue
Vol. 9, no. 11
p. e1001208

Abstract

Read online

A genome-wide screen for large structural variants showed that a copy number variant (CNV) in the region encoding killer cell immunoglobulin-like receptors (KIR) associates with HIV-1 control as measured by plasma viral load at set point in individuals of European ancestry. This CNV encompasses the KIR3DL1-KIR3DS1 locus, encoding receptors that interact with specific HLA-Bw4 molecules to regulate the activation of lymphocyte subsets including natural killer (NK) cells. We quantified the number of copies of KIR3DS1 and KIR3DL1 in a large HIV-1 positive cohort, and showed that an increase in KIR3DS1 count associates with a lower viral set point if its putative ligand is present (p = 0.00028), as does an increase in KIR3DL1 count in the presence of KIR3DS1 and appropriate ligands for both receptors (p = 0.0015). We further provide functional data that demonstrate that NK cells from individuals with multiple copies of KIR3DL1, in the presence of KIR3DS1 and the appropriate ligands, inhibit HIV-1 replication more robustly, and associated with a significant expansion in the frequency of KIR3DS1+, but not KIR3DL1+, NK cells in their peripheral blood. Our results suggest that the relative amounts of these activating and inhibitory KIR play a role in regulating the peripheral expansion of highly antiviral KIR3DS1+ NK cells, which may determine differences in HIV-1 control following infection.